TP53 and lung carcinoma: Expectedly, DPAICP@ME played its predetermined role in vivo through oral administration to restore p53 signaling pathway for cancer therapy in B16F10 homograft malignant melanoma model, LLC Lewis in situ model of lung cancer and PDOX mice model of colon cancer.